Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lynn C Hartmann

Showing results (131-140 of 147) with videos related to

Pageof 15
Sort By:
JNCI Cancer Spectrum|January 9, 2025
Changes in breast cancer risk associated with benign breast disease from 1967 to 2013Amy C Degnim, Karthik Ghosh, Robert A Vierkant, et al.
Cancer Research|January 28, 2010
Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancerEvanthia Galanis, Lynn C Hartmann, William A Cliby, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2014
Tumorgrafts as in vivo surrogates for women with ovarian cancerS John Weroha, Marc A Becker, Sergio Enderica-Gonzalez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 16, 2017
A Phase I Clinical Trial of the Poly(ADP-ribose) Polymerase Inhibitor Veliparib and Weekly Topotecan in Patients with Solid TumorsAndrea E Wahner Hendrickson, Michael E Menefee, Lynn C Hartmann, et al.
Breast Cancer Research : BCR|January 21, 2017
Relationship between crown-like structures and sex-steroid hormones in breast adipose tissue and serum among postmenopausal breast cancer patientsMaeve Mullooly, Hannah P Yang, Roni T Falk, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 4, 2012
Gene set analysis of survival following ovarian cancer implicates macrolide binding and intracellular signaling genesBrooke L Fridley, Gregory D Jenkins, Ya-Yu Tsai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2010
Inherited determinants of ovarian cancer survivalEllen L Goode, Matthew J Maurer, Thomas A Sellers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2017
Bevacizumab May Differentially Improve Ovarian Cancer Outcome in Patients with Proliferative and Mesenchymal Molecular SubtypesStefan Kommoss, Boris Winterhoff, Ann L Oberg, et al.
Human Molecular Genetics|April 11, 2013
Epigenome-wide ovarian cancer analysis identifies a methylation profile differentiating clear-cell histology with epigenetic silencing of the HERG K+ channelMine S Cicek, Devin C Koestler, Brooke L Fridley, et al.
Plos One|January 30, 2010
Risk of ovarian cancer and inherited variants in relapse-associated genesAbraham Peedicayil, Robert A Vierkant, Lynn C Hartmann, et al.
Pageof 15

Showing results (131-140 of 147) with videos related to

Sort By:
Pageof 15
JNCI Cancer Spectrum|January 9, 2025
Changes in breast cancer risk associated with benign breast disease from 1967 to 2013Amy C Degnim, Karthik Ghosh, Robert A Vierkant, et al.
Cancer Research|January 28, 2010
Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancerEvanthia Galanis, Lynn C Hartmann, William A Cliby, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2014
Tumorgrafts as in vivo surrogates for women with ovarian cancerS John Weroha, Marc A Becker, Sergio Enderica-Gonzalez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 16, 2017
A Phase I Clinical Trial of the Poly(ADP-ribose) Polymerase Inhibitor Veliparib and Weekly Topotecan in Patients with Solid TumorsAndrea E Wahner Hendrickson, Michael E Menefee, Lynn C Hartmann, et al.
Breast Cancer Research : BCR|January 21, 2017
Relationship between crown-like structures and sex-steroid hormones in breast adipose tissue and serum among postmenopausal breast cancer patientsMaeve Mullooly, Hannah P Yang, Roni T Falk, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 4, 2012
Gene set analysis of survival following ovarian cancer implicates macrolide binding and intracellular signaling genesBrooke L Fridley, Gregory D Jenkins, Ya-Yu Tsai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2010
Inherited determinants of ovarian cancer survivalEllen L Goode, Matthew J Maurer, Thomas A Sellers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2017
Bevacizumab May Differentially Improve Ovarian Cancer Outcome in Patients with Proliferative and Mesenchymal Molecular SubtypesStefan Kommoss, Boris Winterhoff, Ann L Oberg, et al.
Human Molecular Genetics|April 11, 2013
Epigenome-wide ovarian cancer analysis identifies a methylation profile differentiating clear-cell histology with epigenetic silencing of the HERG K+ channelMine S Cicek, Devin C Koestler, Brooke L Fridley, et al.
Plos One|January 30, 2010
Risk of ovarian cancer and inherited variants in relapse-associated genesAbraham Peedicayil, Robert A Vierkant, Lynn C Hartmann, et al.
Pageof 15